Chan, C. ., Yu, C. ., Lin, J. ., Hsieh, Y. ., Lin, C. ., Hung, C. ., … Wu, T. . (2018). Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study. Cardiovascular Diabetology, 17(1), 20. https://doi.org/10.1186/s12933-018-0663-6 (Original work published 2018)